PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells.

Polycythemia vera (PV) is a human clonal hematologic disorder. Previously we demonstrated that erythroid colony-forming cells (ECFCs) from PV patients contained a hyperactive membrane-associated tyrosine phosphatase. We now show that this phosphatase corresponded to protein tyrosine phosphatase (PTP)-MEG2, an intracellular enzyme with a putative lipid-binding domain. The increased activity of PTP-MEG2 in PV cells is due to its elevated distribution in the membrane fraction. With the development of ECFCs to mature red cells, the protein level of PTP-MEG2 decreased gradually, but membrane-associated PTP-MEG2 was sustained for a longer period of time in PV cells, which correlated with an enhanced colony-forming capability of the cells. Importantly, expression of dominant-negative mutant forms of PTP-MEG2 suppressed in vitro growth and expansion of both normal and PV ECFCs. The data indicate that PTP-MEG2 has an important role in the development of erythroid cells.

[1]  Qingshan Li,et al.  Specific Interaction of Protein Tyrosine Phosphatase-MEG2 with Phosphatidylserine* , 2003, Journal of Biological Chemistry.

[2]  J. Spivak,et al.  Polycythemia vera: myths, mechanisms, and management. , 2002, Blood.

[3]  N. Berlin.  Polycythemia vera: diagnosis and treatment 2002 , 2002, Expert review of anticancer therapy.

[4]  T. Mustelin,et al.  Enlargement of Secretory Vesicles by Protein Tyrosine Phosphatase PTP-MEG2 in Rat Basophilic Leukemia Mast Cells and Jurkat T Cells1 , 2002, The Journal of Immunology.

[5]  A. Tanswell,et al.  Protein-tyrosine Phosphatase MEG2 Is Expressed by Human Neutrophils , 2002, The Journal of Biological Chemistry.

[6]  Z. Zhao,et al.  Purification and characterization of protein tyrosine phosphatase PTP‐MEG2 , 2002, Journal of cellular biochemistry.

[7]  C. Dai,et al.  Increased expression of the INK4a/ARF locus in polycythemia vera. , 2001, Blood.

[8]  C. Sawyers,et al.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. , 2001, The New England journal of medicine.

[9]  B. Neel,et al.  Combinatorial control of the specificity of protein tyrosine phosphatases. , 2001, Current opinion in cell biology.

[10]  M. Lübbert,et al.  Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. , 2000, Blood.

[11]  J. Spivak,et al.  Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. , 1999, Blood.

[12]  C. Ponting,et al.  Sec14p-like domains in NF1 and Dbl-like proteins indicate lipid regulation of Ras and Rho signaling , 1999, Current Biology.

[13]  J. Prchal,et al.  Molecular basis for polycythemia. , 1999, Current opinion in hematology.

[14]  J. Spivak,et al.  Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. , 1998, The New England journal of medicine.

[15]  C. Richard,et al.  Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. , 1998, The New England journal of medicine.

[16]  David A. Williams,et al.  Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. , 1997, Human gene therapy.

[17]  K. Leblanc,et al.  No evidence for an altered mRNA expression or protein level of haematopoietic cell phosphatase in CD34+ bone marrow progenitor cells or mature peripheral blood cells in polycythaemia vera , 1997, European journal of haematology.

[18]  Z. Zhao,et al.  Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells. , 1997, Blood.

[19]  C. Dai,et al.  Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera. , 1997, Blood.

[20]  B. Göttgens,et al.  The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera , 1997, Oncogene.

[21]  A. Green,et al.  Pathogenesis of polycythaemia vera , 1996, The Lancet.

[22]  Paulo N. Correa,et al.  Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor I receptor beta subunit in circulating mononuclear cells of patients with polycythemia vera. , 1995, Blood.

[23]  E. Krebs,et al.  Altered Expression of Protein-tyrosine Phosphatase 2C in 293 Cells Affects Protein Tyrosine Phosphorylation and Mitogen-activated Protein Kinase Activation (*) , 1995, The Journal of Biological Chemistry.

[24]  T. Hunter,et al.  Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling , 1995, Cell.

[25]  A. D’Andrea,et al.  Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera. , 1994, Blood.

[26]  C. Dai,et al.  Polycythaemia vera. III. Burst‐forming units‐erythroid (BFU‐E) response to stem cell factor and c‐kit receptor expression , 1994, British journal of haematology.

[27]  Paulo N. Correa,et al.  Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium [see comments] , 1994 .

[28]  Paulo N. Correa,et al.  Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium. , 1994, Blood.

[29]  J. Dixon,et al.  Protein tyrosine phosphatases. , 2010, Annual review of biochemistry.

[30]  T. Pawson,et al.  Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice , 1993, The Journal of experimental medicine.

[31]  D. Beier,et al.  Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene , 1993, Cell.

[32]  Z. Zhao,et al.  A general peptide substrate for protein tyrosine phosphatases. , 1993, Analytical biochemistry.

[33]  C. Dai,et al.  Polycythemia vera. II: Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor , 1992 .

[34]  P. Majerus,et al.  Cloning and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to retinaldehyde-binding protein and yeast SEC14p. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Dai,et al.  Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor. , 1992, Blood.

[36]  N. Tonks,et al.  Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. , 1991, Science.

[37]  C. Dai,et al.  Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. , 1991, The Journal of clinical investigation.

[38]  L. Shultz,et al.  Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). , 1989, Experimental hematology.

[39]  Conley Cl.  Polycythemia vera, diagnosis and treatment. , 1987 .

[40]  C. Eaves,et al.  Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny. , 1983, Blood.

[41]  W. Vainchenker,et al.  Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum free cultures. , 1982, Blood.

[42]  C. Eaves,et al.  Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera , 1978 .

[43]  R. Hoffman,et al.  Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin. , 1977, The Journal of clinical investigation.

[44]  N. Bersch,et al.  Polycythemia vera: hormonal modulation of erythropoiesis in vitro. , 1977, Blood.

[45]  D. Golde,et al.  Pathogenesis of polycythemia vera—new concepts , 1976, American journal of hematology.

[46]  Prchal Jf,et al.  Letter: Bone-marrow responses in polycythemia vera. , 1974 .

[47]  A. Axelrad,et al.  Letter: Bone-marrow responses in polycythemia vera. , 1974, The New England journal of medicine.